Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
Dina Schneider, Ying Xiong, Andre Roy, Andrew Kaiser, Boro Dropulic, Rimas Orentas
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P122; DOI: 10.1186/2051-1426-3-S2-P122